QEI Interactive CPD Night

QEI Interactive CPD Night

Date: 25/03/2025 (AEST)

Venue: Queensland Eye Institute Woolloongabba 87 Ipswich Rd, Woolloongabba 4102, QLD, 4102

Provider: Queensland Eye Institute

Contact: Brendan Cronin, [E] brendan.cronin@qei.org.au, [P] 07 3239 5000

Activity Outline

An enjoyable evening with education, entertainment and food! Come to catch up, meet friends and hear the latest ophthalmology updates with a series of short interesting interactive talks and discussions all designated to be interesting and relevant for therapeutically endorsed optometrists. 

Please register here: https://qei.zohobackstage.com/QEICPDNight11March#/?lang=en

Learning Objectives

• Understand the role of postoperative topical therapy in the recovery of patients receiving advanced intraocular lenses, including multifocal and extended depth-of-focus (EDOF) IOLs
• Review the evidence supporting the use of intracameral antibiotics in cataract surgery and their impact on postoperative management
• Evaluate the benefits of combined steroid and NSAID therapy in reducing the risk of cystoid macular oedema (CME) following cataract surgery
• Identify common causes of postoperative intraocular pressure (IOP) elevation and strategies for managing steroid-induced ocular hypertension
• Recognize the significance of preservative-free formulations in reducing ocular surface irritation and allergic reactions in postoperative patients
• Understand the differences between DSEK and DMEK surgery
• Understand the advantages of DMEK surgery
• Understand emerging applications of DSEK in perforated corneas
• Understand how ocular therapeutics are applied for DMEK patients in the post-operative period
• Understand the application of ocular therapeutics in cases of corneal transplant rejection
• Understand emerging glaucoma treatments, describing their latest advancements, their mechanism of action and their role in clinical practice
• Evaluate the effectiveness and safety profiles of new glaucoma medications compared to existing treatments
• Discuss the benefits and potential side effects of newer drug classes, such as rho kinase inhibitors
• Determine appropriate candidates for newer glaucoma therapies based on patient-specific factors
• Develop an evidence-based approach to modifying treatment plans for improved intraocular pressure (IOP) control
• Recognize the role of combination therapies and identify situations where combination therapy may be preferable over monotherapy
• Discuss strategies to improve medication adherence, minimize side effects and educate on importance of long-term glaucoma management
• Understand the clinical efficacy of newer agents such as Faricimab in reducing macular edema and macular degeneration and improving visual outcomes
• Understand treatment options for residual macular thickening after surgery
• Recognize initial management strategies for post-surgical pressure elevation
• Demonstrate knowledge of surgical interventions for proliferative diabetic retinopathy, including panretinal photocoagulation and vitrectomy
• Determine whether a case presentation is of typical optic neuritis or not
• Identify the usual prognosis for typical optic neuritis
• Suggest the usual treatments for typical optic neuritis
• Offer other possible differential diagnoses to typical optic neuritis
• Know the first line optometric management of keratoconus
• Know what is an effective anti-allergy management regime for patients with ocular allergy and keratoconus

Max CPD hours awarded: 3.25

Session Information